Chen A, Gupte C, Akhtar K, Smith P, Cobb J (2012) The global economic cost of osteoarthritis: how the UK compares. Arthritis 2012:698709. https://doi.org/10.1155/2012/698709

Article  CAS  PubMed  PubMed Central  Google Scholar 

Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M et al (2012) Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet 380(9859):2163–2196. https://doi.org/10.1016/s0140-6736(12)61729-2

Article  PubMed  PubMed Central  Google Scholar 

Murray CJL (2013) The state of US health, 1990–2010: burden of diseases, injuries, and risk factors. JAMA 310(6):591. https://doi.org/10.1001/jama.2013.13805

Article  CAS  PubMed  Google Scholar 

Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M et al (2014) The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73(7):1323–1330. https://doi.org/10.1136/annrheumdis-2013-204763

Article  PubMed  Google Scholar 

Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N et al (2008) OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 16(2):137–162. https://doi.org/10.1016/j.joca.2007.12.013

Article  CAS  PubMed  Google Scholar 

Harris WH, Sledge CB (1990) Total hip and total knee replacement (1). N Engl J Med 323(11):725–731. https://doi.org/10.1056/NEJM199009133231106

Article  CAS  PubMed  Google Scholar 

Murphy LB, Helmick CG, Schwartz TA, Renner JB, Tudor G, Koch GG et al (2010) One in four people may develop symptomatic hip osteoarthritis in his or her lifetime. Osteoarthritis Cartilage 18(11):1372–1379. https://doi.org/10.1016/j.joca.2010.08.005

Article  CAS  PubMed  PubMed Central  Google Scholar 

Losina E, Thornhill TS, Rome BN, Wright J, Katz JN (2012) The dramatic increase in total knee replacement utilization rates in the United States cannot be fully explained by growth in population size and the obesity epidemic. J Bone Joint Surg Am 94(3):201–207. https://doi.org/10.2106/JBJS.J.01958

Article  PubMed  PubMed Central  Google Scholar 

Kurtz S, Ong K, Lau E, Mowat F, Halpern M (2007) Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 89(4):780–785. https://doi.org/10.2106/JBJS.F.00222

Article  PubMed  Google Scholar 

Patel A, Pavlou G, Mújica-Mota RE, Toms AD (2015) The epidemiology of revision total knee and hip arthroplasty in England and Wales: a comparative analysis with projections for the United States. A study using the National Joint Registry dataset. Bone Joint J. 97-B(8):1076–81. https://doi.org/10.1302/0301-620x.97b8.35170

Article  CAS  PubMed  Google Scholar 

Havelin LI, Engesaeter LB, Espehaug B, Furnes O, Lie SA, Vollset SE (2000) The Norwegian arthroplasty register: 11 years and 73,000 arthroplasties. Acta Orthop Scand 71(4):337–353. https://doi.org/10.1080/000164700317393321

Article  CAS  PubMed  Google Scholar 

Vasso M, Beaufils P, Cerciello S, Schiavone PA (2014) Bone loss following knee arthroplasty: potential treatment options. Arch Orthop Trauma Surg 134(4):543–553. https://doi.org/10.1007/s00402-014-1941-8

Article  PubMed  Google Scholar 

Abu-Amer Y, Darwech I, Clohisy JC (2007) Aseptic loosening of total joint replacements: mechanisms underlying osteolysis and potential therapies. Arthritis Res Ther 9(Suppl 1):S6. https://doi.org/10.1186/ar2170

Article  CAS  PubMed  PubMed Central  Google Scholar 

Russell RGG (2011) Bisphosphonates: the first 40 years. Bone 49(1):2–19. https://doi.org/10.1016/j.bone.2011.04.022

Article  CAS  PubMed  Google Scholar 

Shanbhag AS (2006) Use of bisphosphonates to improve the durability of total joint replacements. J Am Acad Orthop Surg 14(4):215–225. https://doi.org/10.5435/00124635-200604000-00003

Article  PubMed  Google Scholar 

Hilding M, Aspenberg P (2007) Local peroperative treatment with a bisphosphonate improves the fixation of total knee prostheses: a randomized, double-blind radiostereometric study of 50 patients. Acta Orthop 78(6):795–799. https://doi.org/10.1080/17453670710014572

Article  PubMed  Google Scholar 

Hilding M, Aspenberg P (2006) Postoperative clodronate decreases prosthetic migration: 4-year follow-up of a randomized radiostereometric study of 50 total knee patients. Acta Orthop 77(6):912–916. https://doi.org/10.1080/17453670610013213

Article  PubMed  Google Scholar 

Thillemann TM, Pedersen AB, Mehnert F, Johnsen SP, Søballe K (2010) Postoperative use of bisphosphonates and risk of revision after primary total hip arthroplasty: a nationwide population-based study. Bone 46(4):946–951. https://doi.org/10.1016/j.bone.2010.01.377

Article  CAS  PubMed  Google Scholar 

Prieto-Alhambra D, Javaid MK, Judge A, Murray D, Carr A, Cooper C et al (2011) Association between bisphosphonate use and implant survival after primary total arthroplasty of the knee or hip: population based retrospective cohort study. BMJ 343:d7222. https://doi.org/10.1136/bmj.d7222

Article  CAS  PubMed  PubMed Central  Google Scholar 

Teng S, Yi C, Krettek C, Jagodzinski M (2015) Bisphosphonate use and risk of implant revision after total hip/knee arthroplasty: a meta-analysis of observational studies. PLoS ONE 10(10):e0139927. https://doi.org/10.1371/journal.pone.0139927

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hansson U, Toksvig-Larsen S, Ryd L, Aspenberg P (2009) Once-weekly oral medication with alendronate does not prevent migration of knee prostheses: a double-blind randomized RSA study. Acta Orthop 80(1):41–45. https://doi.org/10.1080/17453670902804968

Article  PubMed  PubMed Central  Google Scholar 

Walsh DA, Chapman V (2011) Bisphosphonates for osteoarthritis. Arthritis Res Ther 13(5):128. https://doi.org/10.1186/ar3448

Article  CAS  PubMed  PubMed Central  Google Scholar 

von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP et al (2014) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 12(12):1495–1499. https://doi.org/10.1016/j.ijsu.2014.07.013

Article  Google Scholar 

Prieto-Alhambra D, Lalmohamed A, Abrahamsen B, Arden NK, de Boer A, Vestergaard P et al (2014) Oral bisphosphonate use and total knee/hip implant survival: validation of results in an external population-based cohort: bisphosphonate use and implant survival. Arthritis Rheumatol 66(11):3233–3240. https://doi.org/10.1002/art.38789

Article  CAS  PubMed  Google Scholar 

Kozma C, Dickson Phillips, Meletiche. (2013) Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis. Patient Prefer Adherence. https://doi.org/10.2147/ppa.s40736

Article  PubMed  PubMed Central  Google Scholar 

Fu S-H, Wang C-Y, Yang R-S, Wu F-LL, Hsiao F-Y (2017) Bisphosphonate use and the risk of undergoing total knee arthroplasty in osteoporotic patients with osteoarthritis: a nationwide cohort study in Taiwan. J Bone Joint Surg Am. 99(11):938–46. https://doi.org/10.2106/JBJS.16.00385

Article  PubMed  Google Scholar 

Deyo RA, Cherkin DC, Ciol MA (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45(6):613–619. https://doi.org/10.1016/0895-4356(92)90133-8

Article  CAS  PubMed  Google Scholar 

National Joint Registry. National Joint Registry for England and Wales. 2009

Paling IH (2000) Wear in total hip and knee replacements. J Bone Joint Surg-Am Volume 82(12):1806. https://doi.org/10.2106/00004623-200012000-00020

Article  CAS  Google Scholar 

Carbone LD, Nevitt MC, Wildy K, Barrow KD, Harris F, Felson D et al (2004) The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum 50(11):3516–3525. https://doi.org/10.1002/art.20627

Article  PubMed  Google Scholar 

Vaysbrot EE, Osani MC, Musetti M-C, McAlindon TE, Bannuru RR (2018) Are bisphosphonates efficacious in knee osteoarthritis? A meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 26(2):154–164. https://doi.org/10.1016/j.joca.2017.11.013

Article  CAS  PubMed  Google Scholar 

Kiyomoto K, Iba K, Hanaka M, Ibe K, Hayakawa H, Teramoto A et al (2020) High bone turnover state under osteoporotic changes induces pain-like behaviors in mild osteoarthritis model mice. J Bone Miner Metab 38(6):806–818. https://doi.org/10.1007/s00774-020-01124-y

Article  CAS  PubMed  Google Scholar 

Fernández-Martín S, López-Peña M, Muñoz F, Permuy M, González-Cantalapiedra A (2021) Bisphosphonates as disease-modifying drugs in osteoarthritis preclinical studies: a systematic review from 2000 to 2020. Arthritis Res Ther 23(1):60. https://doi.org/10.1186/s13075-021-02446-6

Article  PubMed  PubMed Central  Google Scholar 

Tande AJ, Patel R (2014) Prosthetic joint infection. Clin Microbiol Rev 27(2):302–345. https://doi.org/10.1128/CMR.00111-13